Debarment and ExclusionsorganizationID: us-medny-7261a140d4bd6c97e2337bf428b606a6c533d2c4

168th Street Drugs INC

Primary Source
US NY MED EXCLUSIONS
Coverage
us
Risk Tier
High
Last Updated
2026-07-26

Compliance Profile

"Risk Warning: Confirming the inclusion of 168th Street Drugs INC (Entity) in global watchlists, including US NY MED EXCLUSIONS. Transactions or engagement may require review."

Banking Impact

Records on US NY MED EXCLUSIONS can trigger enhanced due diligence, compliance holds, counterparty review and documentation requests from banks, investors or procurement teams.

Legal Status

The record should be reviewed against the original source list, jurisdiction and date of publication before decisions are made. Escalation may be required for procurement, onboarding or investor diligence.

Official Source Metadata

Source: Debarment and Exclusions
Full Legal Name168th Street Drugs INC
Source Records
US NY MED EXCLUSIONS
Enforcement TypeDebarment and Exclusions
Identifiers00017963
Risk Topicsdebarment

Associated Subject Network

" Ključavničarstvo ",servisiranje in Montaža Miran Vertačnik S.p.
SI CONFLICTS
"Bruma" Vulkanizerstvo in Prodaja Avtoplaščev Matija Brunskole S.p.
SI CONFLICTS
"Centavria" Elektroinštalacije, Posredovanje in Organiziranje Kulturnih Dejavnosti, Posredovanje Pri Prodaji Blaško Goran S.p.
SI CONFLICTS
"Centralvod" Antun Đuran S.p.
SI CONFLICTS

Compliance Context Review

Independent Risk Assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Export PDFSubscriber Only